Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001161697-19-000336
Filing Date
2019-08-16
Accepted
2019-08-16 14:17:32
Documents
6
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A AMENDMENT NO. 2 TO ANNUAL REPORT FOR 09-30-2018 form_10-k.htm 10-K/A 14455
2 AMENDMENT TO CERTIFICATE OF DESIGNATION SERIES E PREFERRED STOCK ex_3-1.htm EX-3 19742
3 CERTIFICATE OF CORRECTION TO AMENDMENT TO CERTIFICATE OF DESIGNATION ex_3-2.htm EX-3 13554
4 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION ex_31-1.htm EX-31 5995
5 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3208
6 GRAPHIC angiosoma_logo.jpg GRAPHIC 8426
  Complete submission text file 0001161697-19-000336.txt   69790
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-55072 | Film No.: 191032655
SIC: 2834 Pharmaceutical Preparations